Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bachtler, Barbara (1) Bader, Michael Prof. Dr. (20) Bähring, Sylvia Dr. (2) Birchmeier, Walter Prof. Dr. (7) Birchmeier-Kohler, Carmen Prof. Dr. (9) Dechend, Ralf Priv. Doz. (6) Falcke, Martin Prof. Dr. (4) Fielitz, Jens Dr. (1) Gerhardt, Holger Prof. Dr. (6) Gotthardt, Michael Prof. Dr. (4) Heinemann, Udo Prof. Dr. (3) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janz, Martin Dr. (1) Jentsch, Thomas Prof. Dr. (14) Kammertöns, Thomas Dr. (3) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (8) Kettritz, Ralph Prof. Dr. (5) Klußmann, Enno PD Dr. (1) Lee, Young-Ae Prof. Dr. (5) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (3) Luft, Friedrich Prof. Dr. (52) Mathas, Stephan Dr. (1) Morano, Ingo Prof. Dr. (5) Müller, Dominik Prof. Dr. (6) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (3) Pezzutto, Antonio Prof. Dr. (3) Pischon, Tobias Prof. Dr. (2) Rahn, Hans-Peter Dr. (1) Rajewsky, Nikolaus Prof. Dr. (2) Rehm, Armin Dr. (1) Saar, Kathrin Dr. (1) Sander, Maike Prof. Dr. (2) Scheidereit, Claus Prof. Dr. (6) Schlag, Peter M. Prof. Dr. (8) Schulz-Menger, Jeanette Prof. Dr. (5) Sporbert, Anje Dr. (2) Stein, Ulrike Prof. Dr. (8) von Kries, Jens Peter Dr. (1) Waiczies, Sonia PD Dr. (1) Wallukat, Gerd Dr. (2) Walther, Wolfgang Prof. Dr. (7) Wanker, Erich Prof. Dr. (5) Willimsky, Gerald Dr. (3) Willnow, Thomas Prof. Dr. (4) Wolf, Jana Prof. Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (8) 1992 (4) 1993 (7) 1994 (5) 1996 (6) 1997 (9) 1998 (9) 1999 (2) (-) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (9) 2005 (15) 2006 (4) 2007 (6) 2009 (6) 2011 (6) 2013 (16) 2014 (10) 2015 (9) 2016 (14) 2017 (11) 2019 (11) 2020 (5) 2021 (16) 2022 (10) 2023 (10) Molecular Immunology and Gene Therapy (8) 8 Results: Active Filter: Blankenstein, Thomas Prof. Dr.2000 Sort: Result score Newest to oldest Oldest to newest January 01, 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert February 01, 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein January 01, 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein June 01, 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein May 01, 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto May 01, 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel October 01, 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber December 01, 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein
January 01, 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert
February 01, 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
January 01, 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein
June 01, 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein
May 01, 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto
May 01, 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel
October 01, 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber
December 01, 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein